[go: up one dir, main page]

DK1248784T3 - Kondenserede azepiner som vasopressinagonister - Google Patents

Kondenserede azepiner som vasopressinagonister

Info

Publication number
DK1248784T3
DK1248784T3 DK01900169T DK01900169T DK1248784T3 DK 1248784 T3 DK1248784 T3 DK 1248784T3 DK 01900169 T DK01900169 T DK 01900169T DK 01900169 T DK01900169 T DK 01900169T DK 1248784 T3 DK1248784 T3 DK 1248784T3
Authority
DK
Denmark
Prior art keywords
vasopressin agonists
azepines
condensed
condensed azepines
vasopressin
Prior art date
Application number
DK01900169T
Other languages
English (en)
Inventor
Doreen Mary Ashworth
Gary Robert William Pitt
Peter Hudson
Christopher Martyn Yea
Richard Jeremy Franklin
Original Assignee
Ferring Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ferring Bv filed Critical Ferring Bv
Application granted granted Critical
Publication of DK1248784T3 publication Critical patent/DK1248784T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Cephalosporin Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK01900169T 2000-01-05 2001-01-04 Kondenserede azepiner som vasopressinagonister DK1248784T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0000079.4A GB0000079D0 (en) 2000-01-05 2000-01-05 Novel antidiuretic agents
PCT/GB2001/000023 WO2001049682A1 (en) 2000-01-05 2001-01-04 Condensed azepines as vasopressin agonists

Publications (1)

Publication Number Publication Date
DK1248784T3 true DK1248784T3 (da) 2007-10-29

Family

ID=9883168

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01900169T DK1248784T3 (da) 2000-01-05 2001-01-04 Kondenserede azepiner som vasopressinagonister

Country Status (34)

Country Link
US (3) US7074781B2 (da)
EP (1) EP1248784B1 (da)
JP (2) JP3869723B2 (da)
KR (1) KR100605466B1 (da)
CN (1) CN1183129C (da)
AR (1) AR035327A1 (da)
AT (1) ATE366730T1 (da)
AU (1) AU777538B2 (da)
BR (1) BR0107414B1 (da)
CA (1) CA2396277C (da)
CY (1) CY1108034T1 (da)
CZ (1) CZ303444B6 (da)
DE (1) DE60129298T2 (da)
DK (1) DK1248784T3 (da)
EE (1) EE200200367A (da)
ES (1) ES2288923T3 (da)
GB (1) GB0000079D0 (da)
HK (1) HK1046910B (da)
HR (1) HRP20020481B1 (da)
HU (1) HU229937B1 (da)
IL (1) IL149528A0 (da)
MX (1) MXPA02006546A (da)
MY (1) MY140467A (da)
NO (1) NO322571B1 (da)
NZ (1) NZ518803A (da)
PL (1) PL211341B1 (da)
PT (1) PT1248784E (da)
RU (1) RU2259367C2 (da)
SI (1) SI1248784T1 (da)
SK (1) SK287005B6 (da)
UA (1) UA73152C2 (da)
UY (1) UY26521A1 (da)
WO (1) WO2001049682A1 (da)
ZA (1) ZA200205180B (da)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5803659A (en) 1995-12-08 1998-09-08 Chattey; Nigel Modular caissons for use in constructing, expanding and modernizing ports and harbors.
US7138393B2 (en) 1998-07-24 2006-11-21 Wyeth Biologically active vasopressin agonist metabolites
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
HRP20020705A2 (en) * 2000-03-27 2004-12-31 Applied Research Systems Pharmaceutically active pyrrolidine derivatives
IL151911A0 (en) * 2000-03-27 2003-04-10 Applied Research Systems Pyrolidine derivatives, their preparation and pharmaceutical compositions containing them
GB0015601D0 (en) 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
GB0115515D0 (en) * 2001-06-25 2001-08-15 Ferring Bv Oxytocin agonisys
GB0210397D0 (en) * 2002-05-07 2002-06-12 Ferring Bv Pharmaceutical formulations
MXPA05011521A (es) * 2003-04-28 2006-01-23 Astellas Pharma Inc Derivado de 4,4-difluoro-1,2,3,4-tetrahidro-5h-1-benzazepina o una sal del mismo.
PT1530967E (pt) * 2003-11-13 2006-09-29 Ferring Bv Embalagem blister e uma forma de dosagem solida que compreende desmopressina.
JP4943858B2 (ja) * 2004-11-17 2012-05-30 キッセイ薬品工業株式会社 芳香族アミド誘導体、それを含有する医薬組成物およびそれらの医薬用途
CA2602351A1 (en) * 2005-03-25 2006-10-05 Kissei Pharmaceutical Co., Ltd. Urea derivative, medicinal composition containing the same, and medicinal use of these
WO2007052517A1 (ja) * 2005-10-31 2007-05-10 Sumitomo Chemical Company, Limited ヒドロキシ－２－ピロリジンカルボキシアミド化合物の製法
TW200820976A (en) * 2006-09-25 2008-05-16 Kissei Pharmaceutical 1,4-benzodiazepine derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes
BRPI0811204A8 (pt) * 2007-05-10 2015-09-22 Bristol Myers Squibb Co Tetra-hidroibenzo-1,4-diazepinas substituídas por arila e heteroarila e uso das mesmas para bloquear a recaptação de norepinefrina, dopamina e serotonina
WO2009021007A1 (en) 2007-08-06 2009-02-12 Serenity Pharmaceuticals Corporation Methods and devices for desmopressin drug delivery
US20100286045A1 (en) 2008-05-21 2010-11-11 Bjarke Mirner Klein Methods comprising desmopressin
US11963995B2 (en) 2008-05-21 2024-04-23 Ferring B.V. Methods comprising desmopressin
CA2724653A1 (en) * 2008-05-21 2009-11-26 Ferring International Center S.A. Orodispersible desmopressin for increasing initial period of sleep undisturbed by nocturia
GB201005623D0 (en) 2010-04-01 2010-05-19 Vantia Ltd New polymorph
GB201105537D0 (en) * 2011-03-31 2011-05-18 Vantia Ltd New process
WO2020154581A1 (en) 2019-01-24 2020-07-30 Assia Chemical Industries Ltd Solid state forms of fedovapagon-salicyclic acid co-crystal

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3960886A (en) * 1968-07-03 1976-06-01 Sterling Drug Inc. Substituted N-arylanilines
CA1047490A (en) * 1973-04-18 1979-01-30 Friedrich Karrer Ethers
CH599752A5 (da) 1973-04-18 1978-05-31 Ciba Geigy Ag
DE2355454A1 (de) 1973-11-07 1976-10-07 Paul Geisslinger Lochmaschine
EP0186817B1 (en) 1984-12-10 1989-08-02 Nissan Chemical Industries Ltd. 3(2h)pyridazinone, process for its preparation and anti-allergic agent containing it
ES2089033T3 (es) 1989-10-20 1996-10-01 Otsuka Pharma Co Ltd Compuestos benzoheterociclicos.
US5753677A (en) * 1989-10-20 1998-05-19 Otsuka Pharmaceutical Co., Ltd. Benzoheterocyclic compounds
CA2066104C (en) 1991-04-19 2003-05-27 Hidenori Ogawa Benzazepine derivatives as vasopressin antagonists
JPH05320135A (ja) * 1992-05-19 1993-12-03 Yamanouchi Pharmaceut Co Ltd テトラヒドロベンズアゼピン誘導体
TW250481B (da) * 1992-08-20 1995-07-01 Otsuka Pharma Co Ltd
TW270927B (da) * 1992-10-16 1996-02-21 Otsuka Pharma Co Ltd
AU5533894A (en) 1992-11-25 1994-06-22 Yamanouchi Pharmaceutical Co., Ltd. Benzanilide derivative
AU6219994A (en) 1993-03-11 1994-09-26 Yamanouchi Pharmaceutical Co., Ltd. Compound with vasopressin antagonism
GB9307527D0 (en) 1993-04-13 1993-06-02 Fujisawa Pharmaceutical Co New venzamide derivatives,processes for the preparation thereof and pharmaceutical composition comprising the same
US5843952A (en) * 1993-07-29 1998-12-01 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5968930A (en) * 1993-07-29 1999-10-19 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US5760031A (en) * 1993-07-29 1998-06-02 American Cyanamid Company Tricyclic benzazepine vasopressin antagonists
US5516774A (en) 1993-07-29 1996-05-14 American Cyanamid Company Tricyclic diazepine vasopressin antagonists and oxytocin antagonists
US6403577B1 (en) * 1993-11-17 2002-06-11 Eli Lilly And Company Hexamethyleneiminyl tachykinin receptor antagonists
FI1215U1 (fi) * 1993-12-03 1994-02-21 Valmet Paper Machinery Inc Anlaeggning i samband med styrningen av en vira
FR2716194B1 (fr) * 1994-02-14 1996-05-31 Sanofi Elf Dérivés de 3-acylamino-5-phényl-1,4-benzodiazépin-2-one polysubstitués, leur procédé de préparation et les compositions pharmaceutiques les contenant.
JPH08512448A (ja) * 1994-05-06 1996-12-24 フィリップス エレクトロニクス ネムローゼ フェンノートシャップ マイクロ波伝送システム
EP0765314B1 (en) 1994-06-15 2003-05-07 Otsuka Pharmaceutical Company, Limited Benzoheterocyclic derivatives useful as vasopressin or oxytocin modulators
JP2926335B2 (ja) * 1997-06-13 1999-07-28 大塚製薬株式会社 医薬組成物
EP1000062B1 (en) * 1997-07-30 2004-09-22 Wyeth Tricyclic vasopressin agonists
IL133787A0 (en) * 1997-07-30 2001-04-30 American Home Prod Tricyclic vasopressin agonists
EP1119568B1 (en) * 1998-10-09 2004-02-18 Janssen Pharmaceutica N.V. 4,5-dihydro-isoxazole derivatives and their pharmaceutical use
GB2355454A (en) * 1999-10-20 2001-04-25 Ferring Bv Antidiuretic agents
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
GB0015601D0 (en) * 2000-06-26 2000-08-16 Ferring Bv Novel antidiuretic agents
DE10033337A1 (de) 2000-07-08 2002-01-17 Boehringer Ingelheim Pharma Biphenylcarbonsäureamide, ihre Herstellung und ihre Verwendung als Arzneimittel
GB0120051D0 (en) 2001-08-16 2001-10-10 Ferring Bv Oxytocin agonists
GB0224557D0 (en) 2002-10-22 2002-11-27 Glaxo Group Ltd Novel compounds
EP1449844A1 (en) * 2003-02-14 2004-08-25 Ferring B.V. benzamide derivatives as oxytocin agonists and vasopressin antagonists
EP1627876A1 (en) * 2004-08-20 2006-02-22 Ferring B.V. Heterocyclic condensed compounds useful as antidiuretic agents
US7341963B2 (en) * 2005-05-17 2008-03-11 Milliken & Company Non-woven material with barrier skin

Also Published As

Publication number Publication date
US20030087892A1 (en) 2003-05-08
SK287005B6 (sk) 2009-09-07
GB0000079D0 (en) 2000-02-23
AU2384601A (en) 2001-07-16
NO20023137D0 (no) 2002-06-27
NO322571B1 (no) 2006-10-30
UA73152C2 (en) 2005-06-15
PL355808A1 (en) 2004-05-17
HUP0203917A2 (hu) 2003-03-28
KR100605466B1 (ko) 2006-07-28
EE200200367A (et) 2003-12-15
WO2001049682A1 (en) 2001-07-12
BR0107414B1 (pt) 2014-09-16
HRP20020481B1 (hr) 2009-03-31
KR20020063191A (ko) 2002-08-01
PT1248784E (pt) 2007-10-02
JP3869723B2 (ja) 2007-01-17
US7074781B2 (en) 2006-07-11
JP3813629B2 (ja) 2006-08-23
HK1046910B (en) 2007-08-31
ES2288923T3 (es) 2008-02-01
SI1248784T1 (sl) 2007-12-31
NZ518803A (en) 2003-03-28
RU2002120798A (ru) 2004-01-10
EP1248784A1 (en) 2002-10-16
AU777538B2 (en) 2004-10-21
MY140467A (en) 2009-12-31
US7560454B2 (en) 2009-07-14
AR035327A1 (es) 2004-05-12
MXPA02006546A (es) 2002-12-09
EP1248784B1 (en) 2007-07-11
JP2006137767A (ja) 2006-06-01
DE60129298T2 (de) 2008-01-03
NO20023137L (no) 2002-06-27
HRP20020481A2 (en) 2004-08-31
HU229937B1 (hu) 2015-01-28
IL149528A0 (en) 2002-11-10
CN1183129C (zh) 2005-01-05
RU2259367C2 (ru) 2005-08-27
PL211341B1 (pl) 2012-05-31
CY1108034T1 (el) 2013-09-04
JP2003519228A (ja) 2003-06-17
US20080261951A1 (en) 2008-10-23
CA2396277C (en) 2012-03-20
SK9112002A3 (en) 2003-01-09
HUP0203917A3 (en) 2004-07-28
CZ303444B6 (cs) 2012-09-19
CA2396277A1 (en) 2001-07-12
DE60129298D1 (de) 2007-08-23
CZ20022305A3 (cs) 2002-10-16
CN1392875A (zh) 2003-01-22
HK1046910A1 (en) 2003-01-30
ZA200205180B (en) 2004-02-05
BR0107414A (pt) 2002-10-08
UY26521A1 (es) 2001-03-16
ATE366730T1 (de) 2007-08-15
US20060154916A1 (en) 2006-07-13

Similar Documents

Publication Publication Date Title
DK1248784T3 (da) Kondenserede azepiner som vasopressinagonister
NO20025115L (no) Muskarin agonister
NO20030929D0 (no) Guanidinobenzamider som MC4-R agonister
DE50109598D1 (de) Spulenwechseleinrichtung
DK1313481T3 (da) Farmaceutisk sammensætning, som omfatter kondenserede indolforbindelser
DK1226122T3 (da) Bicykliske vasopressin-agonister
CA88796S (fr) Bouteille
CA89020S (fr) Bouteille
UA4263S (uk) Пляшка
UA4576S (uk) Пляшка
UA4038S (uk) Пляшка
UA4066S (uk) Пляшка
UA4104S (uk) Пляшка
UA4113S (uk) Пляшка
UA4204S (uk) Пляшка
UA3765S (uk) Пляшка
UA4310S (uk) Пляшка
UA4311S (uk) Пляшка
UA4312S (uk) Пляшка
UA4355S (uk) Пляшка
UA4356S (uk) Пляшка
UA4364S (uk) Пляшка
UA4412S (uk) Пляшка
UA4440S (uk) Пляшка
UA4504S (uk) Пляшка